Onderneming OpGen Inc Nasdaq
Aandelen
US68373L1098
Biotechnologie & Medisch Onderzoek
Vakgebied
Verkoop per activiteit
USD in miljoen | 2021 | Gewicht | 2022 | Gewicht | Delta |
---|---|---|---|---|---|
Molecular Diagnostics and Informatics
72,6
%
| 3 | 61,7 % | 2 | 72,6 % | -28,71% |
Collaboration
20,7
%
| 1 | 19,4 % | 1 | 20,7 % | -35,32% |
Laboratory Services
6,6
%
| 1 | 18,9 % | 0 | 6,6 % | -78,77% |
Verkoop per regio
USD in miljoen | 2021 | Gewicht | 2022 | Gewicht | Delta |
---|---|---|---|---|---|
International
80,0
%
| 3 | 72,0 % | 2 | 80,0 % | -32,74% |
United States
20,0
%
| 1 | 28,0 % | 1 | 20,0 % | -56,75% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Albert Weber
DFI | Director of Finance/CFO | 60 | 01-01-22 |
Johannes Bacher
COO | Chief Operating Officer | 55 | 01-04-20 |
Oliver Schacht
PRN | Corporate Officer/Principal | 53 | 01-04-20 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Oliver Schacht
PRN | Corporate Officer/Principal | 53 | 01-04-20 |
Bedrijfsgegevens
Sector
Verkoop per activiteit
Verkoop per regio
Vaira. 1 jan. | Kapi. | |
---|---|---|
+22,12% | 46,4 mld. | |
-1,82% | 41,75 mld. | |
+49,11% | 41,37 mld. | |
-3,42% | 29,71 mld. | |
+9,72% | 26,01 mld. | |
-19,27% | 19,52 mld. | |
+30,11% | 12,43 mld. | |
-0,40% | 12,18 mld. | |
-1,25% | 12,13 mld. |